Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Critical Role of LMCD1 in Promoting Profibrotic Characteristics of Lung Myofibroblasts in Experimental and Scleroderma‐Associated Lung Fibrosis

Arthritis & Rheumatology(2022)10.1002/art.42344Source: DataRank Database

Critical Role of LMCD1 in Promoting Profibrotic Characteristics of Lung Myofibroblasts in Experimental and Scleroderma‐Associated Lung Fibrosis is a research paper published in Arthritis & Rheumatology (2022). On theSindex it has a DataRank of 0. It has been cited 20 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access20 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 3.29)OA: greenTopics (46)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Ilia Atanelishvili,Andrew M. Bogatkevich,Richard M. Silver ORCID,Galina S. Bogatkevich ORCID

Live enrichment

PubMed:36103378 PMC:PMC9998340 OpenAlex:https://openalex.org/W4295709194

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Grant: P30-AR-072582

National Institute of General Medical Sciences

Grant: P30-GM-103342

National Scleroderma Foundation

FWCI

3.29

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

2026

greenLicense: http://onlinelibrary.wiley.com/termsAndConditions#vor

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC9998340/pdf/nihms-1835383.pdf

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/art.42344

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/art.42344

publisherhttps://acrjournals.onlinelibrary.wiley.com/doi/pdf/10.1002/art.42344

Fields of Study

Systemic Sclerosis and Related DiseasesInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisConnective Tissue Growth Factor ResearchAnimalsMicePulmonary FibrosisMyofibroblastsScleroderma, SystemicLung Diseases, InterstitialLungFibroblastsScleroderma, LocalizedCo-Repressor ProteinsLIM Domain Proteins

MeSH Terms

AnimalsFibroblastsLungPulmonary FibrosisScleroderma, LocalizedScleroderma, SystemicLung Diseases, InterstitialMiceCo-Repressor ProteinsMyofibroblastsLIM Domain Proteins

Keywords

FibronectinMyofibroblastInterstitial lung diseaseLungExtracellular matrixPulmonary fibrosisTransforming growth factorFibrosisFibroblastBleomycinPathologyScleroderma (fungus)Growth factorMedicineCancer researchBiologyEndocrinologyInternal medicineReceptorCell biologyCell culture

Sustainable Development Goals

SDG 0: Good health and well-being